Profil
Stanley W.
Merrill has been Vice President-Human Resources of Targanta Therapeutics Corp.
since March 2007.
He has over 20 years of experience in Human Resources emphasizing Employment, Employee Relations, Organizational Development, Business Partnering, Compensation, Recruiting Management and Sales.
From July 2004 to March 2007, Mr. Merrill held various positions at Acambis, Inc., most recently as Director of Human Resources and Acting Vice President-Human Resources.
From February 2002 to July 2004, he was President and Chief Executive Officer at Merrill Placements, Inc. Mr. Merrill received an MBA degree from Babson College and a BA degree in Geology from the University of Vermont.
Anciens postes connus de Stanley W. Merrill
| Sociétés | Poste | Fin |
|---|---|---|
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Responsable des Ressources Humaines | 01/03/2007 |
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | Responsable des Ressources Humaines | - |
Formation de Stanley W. Merrill
| Babson College | Masters Business Admin |
| University of Vermont | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Targanta Therapeutics Corp.
Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | Health Technology |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
